European equities traded in the US as American depositary receipts were falling on Thursday morning, down 0.2% to 1,525.94 on the S&P Europe Select ADR Index.
From continental Europe, the gainers were led by insurer Aegon (AEG) and biopharmaceutical firm DBV Technologies (DBVT), which rose 7.2% and 4.1%, respectively.
They were followed by biotech firm Evaxion (EVAX) and pharmaceutical giant Novo Nordisk (NVO), which added 2.7% and 2.1%.
The decliners from continental Europe were led by biopharmaceutical company Cellectis (CLLS) and steel maker ArcelorMittal (MT), which fell 3.2% and 2.7%, respectively.
From the UK and Ireland, the gainers were led by pharmaceutical companies Adaptimmune Therapeutics (ADAP) and Centessa Pharmaceuticals (CNTA), which rose 5.4% and 1.8%, respectively.
The decliners from the UK and Ireland were led by cryptocurrency miner Argo Blockchain (ARBK), which was down 2.5%.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。